Investing.com - BioNTech (NASDAQ: BNTX) reported first quarter EPS of €1.90, €0.46 worse than the analyst estimate of €2.36. Revenue for the quarter came in at €1.48B versus the consensus estimate of €2.02B.
BioNTech's stock price closed at €94.12. It is down -10.64% in the last 3 months and down -29.41% in the last 12 months.
BioNTech saw 3 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See BioNTech's stock price’s past reactions to earnings here.
According to InvestingPro, BioNTech's Financial Health score is "excellent performance".
Check out BioNTech's recent earnings performance, and BioNTech's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar